Clinical trial
Azithromycin Plus Chloroquine Versus Mefloquine for the Treatment of…
NCT00082576 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00082576 |
|---|---|
| Title | Azithromycin Plus Chloroquine Versus Mefloquine for the Treatment of Uncomplicated Malaria in Africa |
| Official title | A Phase II/III, Randomized, Double-Blind, Comparative Trial Of Azithromycin Plus Chloroquine Versus Mefloquine For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In Africa |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Malaria, Falciparum |
| Intervention type | Drug |
| Interventions | Azithromycin/Chloroquine, Mefloquine |
| Enrollment | 238 |
| Start date | Jun 1, 2004 |
| Completion | May 1, 2006 |
| First posted | May 14, 2004 |
| Last update posted | May 11, 2011 |
| Countries | Ghana, Mali, Uganda, Zambia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: